Primary outcome · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Activities of daily living · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury
The review found no eligible studies for this question.
2 findings from 1 review
Secondary outcomes · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neglect outcomes: effects persisting at least 1 month post intervention · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neglect outcomes: immediate effects · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury
It is very uncertain whether movement interventions changes neglect outcomes: immediate effects compared with any control (very low certainty).
1 finding from 1 review
Adverse events · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal movements ‐ gross body and limb (Degree of fetal immobilisation as defined by trial authors) · health problem or population
1 finding from 1 review
Time from completion of operation to first bowel movement (hours) · postpartum women who underwent surgical repair of third degree perineal tears
1 finding from 1 review
Time to first BM (№ women with 1st BM on day 1 after delivery) · women in the postpartum period
Laxative may leads to higher time to first bowel movement (BM) (№ women with 1st BM less than 24… compared with placebo (low certainty).
1 finding from 1 review
Change from baseline in passive ankle dorsiflexion range of movement · children with ITW gait
1 finding from 1 review
Neuromusculoskeletal and movement‐related functions at 12 weeks (measured by ankle dorsiflexion) · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
1 finding from 1 review
Neuromusculoskeletal and movement‐related functions post treatment (measured by range of movement) · children/young people aged 4‐18 years with traumatic brain injury and with 'mild to severe spastic tetraparesis' (weakness) in all limbs
1 finding from 1 review
Neuromusculoskeletal and movement‐related functions up to 6 hours after treatment (Measured by spasm and deep tendon reflex scores, 0‐5, with 0 being no reflexes and 5 being clonus, or repeated involuntary muscle contractions) · adults with traumatic brain injury with spasticity in their arms and legs
1 finding from 1 review
Improvement in ocular motility (ocular alignment ≤ 10 prism dioptres). · people with sixth nerve palsy
Botulinum toxin showed no clear difference in improvement in ocular motility (ocular alignment ≤ 10 prism dioptres). compared with observation (low certainty).
1 finding from 1 review
Secondary outcome: achievement of binocular single vision · people with sixth nerve palsy
Botulinum toxin showed no clear difference in achievement of binocular single vision (fusion and stereopsis… compared with observation (low certainty).
1 finding from 1 review
Improvement in functional ability · people with sixth nerve palsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with sixth nerve palsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events. · people with sixth nerve palsy
1 finding from 1 review
Intervention not reported
Gabapentin up to 900 mg/day) versus baclofen (up to 30 mg/day). · people with acquired nystagmus
1 finding from 1 review
Intervention not reported
3,4‐DAP (20 mg, single dose) versus placebo. Assessments made 30 minutes after taking the drug or placebo · people with acquired nystagmus
1 finding from 1 review